ISPOR Europe 2023 Home
Toggle navigation
About
News Center
Award Winners
Program
Program
Student Program
Learning Formats
Plenary Sessions
Posters
Program Committee
Digital Conference Pass
Exhibits & Sponsorship
Sponsor List
Exhibitor Directory
Media Partners
Photo Gallery
ISPOR
Europe 2023
12 - 15 November
Home
Events
Past Conferences
ISPOR Europe 2023
Program
Program
Session
A Propensity Score-Based Comparison of Tepotinib Versus Immunotherapy with/without Chemotherapy, Using Real-World Data in Previously Untreated Met Exon 14 (METEX14) Skipping Non‑Small Cell Lung Cancer (NSCLC)
Nov 15, 2023, 09:00 AM
«
101
(current)
102
103
104
105
106
107
108
109
110
»